Polish medical booking platform DocPlanner nets $10 mln

By Iris Dorbian — 9 months ago

Warsaw, Poland-based medical booking platform DocPlanner has raised $10 million in Series B funding. European Bank for Reconstruction and Development via its Venture Capital Investment Programme and Lukasz Gadowsk led the round with participation from other investors that included Nine Capital, Piton Capital and RTAventures.

Continue

Innova Capital Backs Romanian EnergoBit

By Angela Sormani — 3 years ago

Central European private equity fund Innova Capital and the European Bank for Reconstruction and Development are investing in EnergoBit Group, an electrical engineering services company in Romania. Innova Capital will become a controlling shareholder in the company.

Continue

Reuters – EBRD Backs Turkey with a Billion

By Reuters News — 3 years ago

The European Bank for Reconstruction and Development (EBRD) expects to invest at least 1 billion euros ($1.3 bln) in Turkey next year, writes Reuters. The EBRD started operations in Turkey in 2009 and has invested around 2 billion euros since then, much of it in small and medium-sized companies in remote regions which struggled to […]

Continue

CapMan Russia Backs KDL Test

By Angela Sormani — 4 years ago

CapMan Russia, a fund managed by CapMan, has acquired a 24 percent stake in KDL Test, a chain of private diagnostic laboratories in Russia. The investment has been made jointly with the European Bank for Reconstruction and Development and UFG Private Equity. PRESS RELEASE CapMan Russia, a fund managed by CapMan, has acquired a 24 […]

Continue

EBRD Backs Energy-Saving Glass J-V

By Angela Sormani — 4 years ago

State-owned Russian technology company Rusnano is investing in a 295 million euro ($397 million) joint venture with Japan’s Nippon Sheet Glass and the European Bank for Reconstruction and Development (EBRD) to produce energy-saving glass, writes Reuters. The EBRD said it will contribute the equivalent of 35 million euros , which, according to state-owned Rusnano, will […]

Continue